A multicenter trial comparing the luteinizing hormone releasing hormone analog Zoladex, with Zoladex plus flutamide in the treatment of advanced prostate cancer. The International Prostate Cancer Study Group.
Lunglmayr
G
G
Hospital Mistelbach, Austria.
D002064:Buserelin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005485:Flutamide / Q000009:adverse effects / Q000627:therapeutic use*; D017273:Goserelin; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D017273:Goserelin; D005485:Flutamide; D002064:Buserelin